NCT06910150

Brief Summary

The anterior cruciate ligament (ACL) injury is one of the most prevalent injuries in the musculoskeletal system. Consequently, its surgical reconstruction is among the most commonly performed procedures in current clinical practice. The aim of this clinical trial is to investigate if the application of a single session of electrical currents to the quadriceps muscle can reduce pain in individuals who have undergone ACL surgery. Additionally, the trial will assess whether this intervention increases the pressure pain threshold, mobility, strength and functionality of the operated knee, as well as improving the participant's quality of life. Effusion and edema of the operated knee will also be measured. Participants in this clinical trial will be randomly assigned to three study groups: one control group and two experimental groups. All participants will undergo a conventional physiotherapy program for knee rehabilitation. This program includes manual therapy with a physiotherapist and exercises aimed at strengthening the CORE, hip and knee muscles. Participants in the first experimental group will receive an additional session of superficial (non-invasive) electrical currents applied to the quadriceps muscle of the operated knee. Participants in the second experimental group will receive an additional session of invasive electrical currents applied to the quadriceps muscle of the operated knee. Each patient will be assessed four times: before the intervention, immediately after the intervention, and 1 and 7 days post-intervention. Functionality of the operated knee and quality of life will only be assessed before the intervention and 7 days post-intervention using self-reported scales.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2025

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 18, 2025

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 18, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

March 27, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 4, 2025

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 25, 2026

Completed
Last Updated

December 10, 2025

Status Verified

March 1, 2025

Enrollment Period

Same day

First QC Date

March 27, 2025

Last Update Submit

December 2, 2025

Conditions

Outcome Measures

Primary Outcomes (10)

  • Change in knee pain from baseline to immediately after the intervention, as well as at one and seven days post-intervention.

    Assessed with the Numeric Rating Scale (NRS). The patient reports their pain at the moment of measurement on a scale from 0 (no pain) to 10 (worst imaginable pain).

    From baseline to immediately after the intervention, as well as at one and seven days post-intervention.

  • Change in knee range of movement from baseline to immediately after the intervention, as well as at one and seven days post-intervention.

    Assessed with a manual universal goniometer.

    From baseline to immediately after the intervention, as well as at one and seven days post-intervention.

  • Change in knee pain threshold to pressure from baseline to immediately after the intervention, as well as at one and seven days post-intervention.

    Assessed with an analog algometer (FPK 20).

    From baseline to immediately after the intervention, as well as at one and seven days post-intervention.

  • Change in maximum isometric quadriceps strength from baseline to immediately after the intervention, as well as at one and seven days post-intervention.

    Assessed with a portable handheld dynamometer Lafayette© (Lafayette Manual Muscle Tester, Lafayette Instruments, Lafayette, IN)

    From baseline to immediately after the intervention, as well as at one and seven days post-intervention.

  • Change in thigh muscle atrophy from baseline to immediately after the intervention, as well as at one and seven days post-intervention.

    Assessed with a flexible measuring tape.

    From baseline to immediately after the intervention, as well as at one and seven days post-intervention.

  • Change in knee intra-articular effusion from baseline to immediately after the intervention, as well as at one and seven days post-intervention.

    Assessed on the basis of bulge and dancing patella signs and reported as 3 (\>60 cm3 - tight capsule), 2 (25-60 cm3 - visible), 1(\<25 cm3 - palpable by smoothing out the joint capsule), or 0 (no effusion).

    From baseline to immediately after the intervention, as well as at one and seven days post-intervention.

  • Change in knee extra-articular edema from baseline to immediately after the intervention, as well as at one and seven days post-intervention.

    Assessed with a flexible measuring tape.

    From baseline to immediately after the intervention, as well as at one and seven days post-intervention.

  • Change in quality of life from baseline to seven days post-intervention.

    Assessed with the self-reported scale "Anterior Cruciate Ligament - Quality of Life - Spanish". Potential score: 0-3200. The higher the score, the better the patient's quality of life..

    From baseline to seven days post-intervention.

  • Change in knee functionality from baseline to seven days post-intervention.

    Assessed with the self-reported questionnaire "Lysholm Scale". Potential score: 0-100 points. The higher the score, the better the patient's functionality.

    From baseline to seven days post-intervention.

  • Needle apprehension at baseline

    Assessed with the self-reported questionnaire "Personal Psychological Apprehension Scale in Physiotherapy". Potential score: 15-60 points. The higher the score, the worse the patient's situation. If the participant scored higher than 37.5 points at baseline, they were excluded from the study (exclusion criteria).

    At baseline

Study Arms (3)

Control group

NO INTERVENTION

Participants will only undergo a conventional physiotherapy rehabilitation program for anterior cruciate ligament rehabilitation.

Experimental Group 1

EXPERIMENTAL

Participants will undergo a conventional anterior cruciate ligament rehabilitation physiotherapy program and receive a single session of analgesic transcutaneous electrical nerve stimulation (TENS).

Procedure: Non-invasive analgesic electrostimulation

Experimental Group 2

EXPERIMENTAL

Participants will undergo a conventional anterior cruciate ligament rehabilitation physiotherapy program and receive a single session of invasive analgesic electrostimulation (LTP, long-term potentiation).

Procedure: Invasive analgesic electrostimulation

Interventions

A single session of non-invasive analgesic electrostimulation is applied to the motor points of the vastus medialis and vastus lateralis muscles of the quadriceps femoris in patients who had undergone anterior cruciate ligament reconstruction. A biphasic, symmetrical, square-wave current is used at a frequency of 100 Hz, a pulse width of 200 μs, and an intensity adjusted to the patient's pain threshold, applied for 30 minutes.

Also known as: TENS (Transcutaneous Electrical Nerve Stimulation)
Experimental Group 1

A single session of invasive analgesic electrostimulation is applied to a motor point of the vastus medialis of the quadriceps femoris in patients who had undergone anterior cruciate ligament reconstruction. A biphasic, symmetrical, square-wave current is used at a frequency of 100 Hz, a pulse width of 250 μs, and an intensity defined as perceptible to the patient but never painful (200 μA above the detection threshold for each subject).

Also known as: LTP protocol (long-term potentiation)
Experimental Group 2

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Subjects aged between 18 and 55 years, regardless of gender.
  • Subjects who have undergone surgical ACL reconstruction within the past six weeks, with or without additional procedures on one or both menisci due to their high concomitance, and with or without Lemaire reinforcement in the form of extra-articular lateral tenodesis.
  • Subjects experiencing pain in the operated knee.
  • Voluntary signing of the informed consent form for the study.

You may not qualify if:

  • Contraindications for invasive therapies:
  • Subjects with chronic joint pathology.
  • Subjects with prostheses or osteosynthesis in the affected lower limb.
  • Subjects with heart disease.
  • Subjects with neoplasms.
  • Subjects with coagulopathies.
  • Subjects with epilepsy.
  • Subjects with pacemakers.
  • Pregnant patients.
  • Subjects with belonephobia (severe fear of needles).
  • Subjects with neuropathic pain.
  • Subjects with central nervous system disorders.
  • Subjects with a history of neurological disorders.
  • Subjects with a history of lumbar hernia or protrusion due to a possible involvement of the lumbar plexus.
  • Subjects with a history of spinal surgery.
  • +11 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clínica CEMTRO

Madrid, Madrid, 28035, Spain

Location

MeSH Terms

Interventions

Transcutaneous Electric Nerve StimulationLong-Term Potentiation

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsPhysical Therapy ModalitiesRehabilitationAnalgesiaAnesthesia and AnalgesiaNeuronal PlasticityNervous System Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Luis Blanco-López, Physiotherapy

    Universidad Católica San Antonio de Murcia (UCAM)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator at Universidad Católica San Antonio de Murcia

Study Record Dates

First Submitted

March 27, 2025

First Posted

April 4, 2025

Study Start

February 18, 2025

Primary Completion

February 18, 2025

Study Completion

February 25, 2026

Last Updated

December 10, 2025

Record last verified: 2025-03

Locations